You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
25 October 2023
Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology
22 August 2023
ViGeneron announces EMA Approval of Clinical Trial Application for VG901, a gene therapy to treat Retinitis Pigmentosa
11 October 2022
ViGeneron presents preclinical data on intravitreal gene therapy of Stargardt disease at ESGCT
26 April 2022
ViGeneron announces follow-on collaboration with Daiichi Sankyo to develop a novel gene therapy for prevalent eye diseases
6 April 2022
ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target
18 January 2021
ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ophthalmic gene therapy
5 January 2021
ViGeneron signs global collaboration agreement for ophthalmic gene therapy development
1 December 2020
ViGeneron and WuXi Advanced Therapies enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy
28 November 2019
ViGeneron announces closing of series A financing to drive development of next generation gene therapy pipeline
